Javier Vázquez-Bourgón

2.4k total citations
77 papers, 793 citations indexed

About

Javier Vázquez-Bourgón is a scholar working on Psychiatry and Mental health, Clinical Psychology and Physiology. According to data from OpenAlex, Javier Vázquez-Bourgón has authored 77 papers receiving a total of 793 indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Psychiatry and Mental health, 17 papers in Clinical Psychology and 13 papers in Physiology. Recurrent topics in Javier Vázquez-Bourgón's work include Schizophrenia research and treatment (48 papers), Bipolar Disorder and Treatment (25 papers) and Diet and metabolism studies (10 papers). Javier Vázquez-Bourgón is often cited by papers focused on Schizophrenia research and treatment (48 papers), Bipolar Disorder and Treatment (25 papers) and Diet and metabolism studies (10 papers). Javier Vázquez-Bourgón collaborates with scholars based in Spain, United Kingdom and United States. Javier Vázquez-Bourgón's co-authors include Benedicto Crespo‐Facorro, Víctor Ortiz‐García de la Foz, Rosa Ayesa‐Arriola, Marcos Gómez‐Revuelta, Esther Setién‐Suero, María Juncal‐Ruíz, José María Pelayo‐Terán, Jacqueline Mayoral-van Son, José Luis Vázquez‐Barquero and Paula Suárez‐Pinilla and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and American Journal of Psychiatry.

In The Last Decade

Javier Vázquez-Bourgón

70 papers receiving 783 citations

Peers

Countries citing papers authored by Javier Vázquez-Bourgón

Since Specialization

Citations

This map shows the geographic impact of Javier Vázquez-Bourgón's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Javier Vázquez-Bourgón with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Javier Vázquez-Bourgón more than expected).

Fields of papers citing papers by Javier Vázquez-Bourgón

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Javier Vázquez-Bourgón. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Javier Vázquez-Bourgón. The network helps show where Javier Vázquez-Bourgón may publish in the future.

Co-authorship network of co-authors of Javier Vázquez-Bourgón

This figure shows the co-authorship network connecting the top 25 collaborators of Javier Vázquez-Bourgón. A scholar is included among the top collaborators of Javier Vázquez-Bourgón based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Javier Vázquez-Bourgón. Javier Vázquez-Bourgón is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Predicting clinical and functional trajectories in individuals with first-episode psychosis by baseline deviations in grey matter volume 2025 ·The British Journal of Psychiatry ·(unknown), (unknown), (unknown), Nathalia Garrido‐Torres, (unknown), Richard A. I. Bethlehem, Lena Dorfschmidt, Jakob Seidlitz, Rosa Ayesa‐Arriola, Javier Vázquez-Bourgón, Miguel Ruíz-Veguilla, Benedicto Crespo‐Facorro, Rafael Romero-García	0
2	Anthropometry in antipsychotic-naïve first-episode psychosis patients: An exploratory approach to the role of environmental early life events in two independent samples 2024 ·Schizophrenia Research ·Clemente García‐Rizo, Benedicto Crespo‐Facorro, Cristina Oliveira, Marcos Gómez‐Revuelta, Brian Kirkpatrick, Jacqueline Mayoral-van Son, (unknown), Marina Garriga, Nathalia Garrido‐Torres, Miquel Bernardo, Emilio Fernández-Egea, Javier Vázquez-Bourgón	2
3	Clinical simulation: A useful and underutilized training tool for the present and the future of learning in psychiatry 2023 ·PubMed ·Andrés Gómez del Barrio, Javier Vázquez-Bourgón, (unknown), José M. Maestre, Marcos Gómez‐Revuelta	0
4	Increased risk of early lung function alterations in people with psychosis: A cross-sectional case–control study 2023 ·PubMed ·(unknown), Carlos Antonio Amado Diago, (unknown), Marcos Gómez‐Revuelta, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Benedicto Crespo‐Facorro, Javier Vázquez-Bourgón	0
5	Polygenic risk scores enhance prediction of body mass index increase in individuals with a first episode of psychosis 2023 ·European Psychiatry ·Gerard Muntané, Javier Vázquez-Bourgón, (unknown), Lourdes Martorell, Sergi Papiol, Elena Bosch, Arcadi Navarro, Benedicto Crespo‐Facorro, Elisabet Vilella	9
6	Longitudinal trajectories in negative symptoms and changes in brain cortical thickness: 10-year follow-up study 2023 ·The British Journal of Psychiatry ·Manuel Canal‐Rivero, Miguel Ruíz-Veguilla, Víctor Ortiz‐García de la Foz, Álvaro López‐Díaz, Nathalia Garrido‐Torres, Rosa Ayesa‐Arriola, Javier Vázquez-Bourgón, Jacqueline Mayoral-van Son, Paolo Brambilla, Tilo Kircher, Rafael Romero-García, Benedicto Crespo‐Facorro	13
7	Metabolic syndrome and related factors in a large sample of antipsychotic naïve patients with first-episode psychosis: 3 years follow-up results from the PAFIP cohort 2022 ·PubMed ·Nathalia Garrido‐Torres, Miguel Ruíz-Veguilla, (unknown), (unknown), Manuel Canal‐Rivero, María Juncal‐Ruíz, Marcos Gómez‐Revuelta, Rosa Ayesa‐Arriola, Benedicto Crespo‐Facorro, Javier Vázquez-Bourgón	3
8	Aripiprazole vs Risperidone Head-to-Head Effectiveness in First-Episode Non-Affective-Psychosis: A 3-Month Randomized, Flexible-Dose, Open-Label Clinical Trial 2022 ·The International Journal of Neuropsychopharmacology ·(unknown), Marcos Gómez‐Revuelta, Víctor Ortiz‐García de la Foz, José María Pelayo‐Terán, (unknown), Miguel Ruíz-Veguilla, Jacqueline Mayoral-van Son, Rosa Ayesa‐Arriola, Javier Vázquez-Bourgón, Benedicto Crespo‐Facorro	2
9	Gene set enrichment analysis of pathophysiological pathways highlights oxidative stress in psychosis 2022 ·Molecular Psychiatry ·Giorgio Pistis, Javier Vázquez-Bourgón, Margot Fournier, Raoul Jenni, Martine Cleusix, Sergi Papiol, Sophie E. Smart, Antonio F. Pardiñas, James Walters, James H. MacCabe, Zoltán Kutalik, Philippe Conus, Benedicto Crespo‐Facorro, Kim Q.	9
10	Peripheral lymphocyte signaling pathway deficiencies predict treatment response in first-onset drug-naïve schizophrenia 2022 ·Brain Behavior and Immunity ·(unknown), Jakub Tomasik, (unknown), Nitin Rustogi, Javier Vázquez-Bourgón, Sergi Papiol, Paula Suárez‐Pinilla, Benedicto Crespo‐Facorro, Sabine Bahn	9
11	Stability of schizophrenia diagnosis in a 10‐year longitudinal study on first episode of non‐affective psychosis: Conclusions from the PAFIP cohort 2021 ·Acta Psychiatrica Scandinavica ·Paula Suárez‐Pinilla, Marta Suárez‐Pinilla, Esther Setién‐Suero, Víctor Ortiz‐García de la Foz, Jacqueline Mayoral-van Son, Javier Vázquez-Bourgón, Marcos Gómez‐Revuelta, María Juncal‐Ruíz, Rosa Ayesa‐Arriola, Benedicto Crespo‐Facorro	2
12	Comparison of aripiprazole and risperidone effectiveness in first episode non-affective psychosis: Rationale and design of a prospective, randomized, 3-phase, investigator-initiated study (PAFIP-3) 2021 ·Revista de Psiquiatría y Salud Mental (English Edition) ·Jacqueline Mayoral-van Son, Marcos Gómez‐Revuelta, Rosa Ayesa‐Arriola, Javier Vázquez-Bourgón, Víctor Ortiz‐García de la Foz, Miguel Ruíz-Veguilla, Nathalia Garrido‐Torres, Diana Tordesillas‐Gutiérrez, Esther Setién‐Suero, Benedicto Crespo‐Facorro	8
13	Cognitive reserve as a moderator of outcomes in five clusters of first episode psychosis patients: a 10-year follow-up study of the PAFIP cohort 2021 ·Psychological Medicine ·Rosa Ayesa‐Arriola, Víctor Ortiz‐García de la Foz, (unknown), Javier Vázquez-Bourgón, María Juncal‐Ruíz, Marcos Gómez‐Revuelta, Paula Suárez‐Pinilla, Esther Setién‐Suero, Benedicto Crespo‐Facorro	10
14	Expression and Functionality Study of 9 Toll-Like Receptors in 33 Drug-Naïve Non-Affective First Episode Psychosis Individuals: A 3-Month Study 2020 ·International Journal of Molecular Sciences ·María Juncal‐Ruíz, (unknown), Javier Vázquez-Bourgón, Víctor Ortiz‐García de la Foz, Jacqueline Mayoral-van Son, Rosa Ayesa‐Arriola, Esther Setién‐Suero, Juan C. Leza, Marcos López‐Hoyos, Benedicto Crespo‐Facorro	6
15	Treatment Discontinuation Impact on Long-Term (10-Year) Weight Gain and Lipid Metabolism in First-Episode Psychosis: Results From the PAFIP-10 Cohort 2020 ·The International Journal of Neuropsychopharmacology ·Javier Vázquez-Bourgón, (unknown), Marcos Gómez‐Revuelta, María Juncal‐Ruíz, Víctor Ortiz‐García de la Foz, Diana Tordesillas‐Gutiérrez, Rosa Ayesa‐Arriola, Miquel Bioque, Benedicto Crespo‐Facorro	14
16	Antipsychotic Treatment Effectiveness in First Episode of Psychosis: PAFIP 3-Year Follow-Up Randomized Clinical Trials Comparing Haloperidol, Olanzapine, Risperidone, Aripiprazole, Quetiapine, and Ziprasidone 2020 ·The International Journal of Neuropsychopharmacology ·Marcos Gómez‐Revuelta, José María Pelayo‐Terán, María Juncal‐Ruíz, Javier Vázquez-Bourgón, Paula Suárez‐Pinilla, (unknown), Esther Setién‐Suero, Rosa Ayesa‐Arriola, Benedicto Crespo‐Facorro	47
17	Dissecting the functional outcomes of first episode schizophrenia spectrum disorders: a 10-year follow-up study in the PAFIP cohort 2019 ·Psychological Medicine ·Rosa Ayesa‐Arriola, Víctor Ortiz‐García de la Foz, Obdulia Martínez‐García, Esther Setién‐Suero, (unknown), Paula Suárez‐Pinilla, Jacqueline Mayoral-van Son, Javier Vázquez-Bourgón, María Juncal‐Ruíz, Marcos Gómez‐Revuelta, Diana Tordesillas‐Gutiérrez, Benedicto Crespo‐Facorro	19
18	Diferencias en la efectividad clínica y funcional, entre trastornos psiquiátricos, de un hospital de día psiquiátrico de agudos para pacientes con enfermedad mental aguda 2019 ·Revista de Psiquiatría y Salud Mental ·Javier Vázquez-Bourgón, (unknown), (unknown), Luis Salvador‐Carulla, Rosa Ayesa‐Arriola, (unknown), Benedicto Crespo‐Facorro	3
19	Age of onset of Cannabis use and cognitive function in first-episode non-affective psychosis patients: Outcome at three-year follow-up 2018 ·Schizophrenia Research ·Esther Setién‐Suero, Obdulia Martínez‐García, Víctor Ortiz‐García de la Foz, Javier Vázquez-Bourgón, Patricia Correa‐Ghisays, Adele Ferro, Benedicto Crespo‐Facorro, Rosa Ayesa‐Arriola	9
20	Variations in Disrupted-in-Schizophrenia 1 gene modulate long-term longitudinal differences in cortical thickness in patients with a first-episode of psychosis 2015 ·Brain Imaging and Behavior ·Javier Vázquez-Bourgón, Roberto Roiz‐Santiáñez, Sergi Papiol, Adele Ferro, (unknown), Lourdes Fañanás, Benedicto Crespo‐Facorro	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact